These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 23085605

  • 1. Different domains of glycoprotein 96 influence HPV16 E7 DNA vaccine potency via electroporation mediated delivery in tumor mice model.
    Daemi A, Bolhassani A, Rafati S, Zahedifard F, Hosseinzadeh S, Doustdari F.
    Immunol Lett; 2012 Dec 17; 148(2):117-25. PubMed ID: 23085605
    [Abstract] [Full Text] [Related]

  • 2. The contribution of NT-gp96 as an adjuvant for increasing HPV16 E7-specific immunity in C57BL /6 mouse model.
    Mohit E, Bolhassani A, Zahedifard F, Taslimi Y, Rafati S.
    Scand J Immunol; 2012 Jan 17; 75(1):27-37. PubMed ID: 21916914
    [Abstract] [Full Text] [Related]

  • 3. Immuno-Stimulating Peptide Derived from HMGB1 is More Effective Than the N-Terminal Domain of Gp96 as an Endogenous Adjuvant for Improvement of Protein Vaccines.
    Talebi S, Bolhassani A, Azad TM, Arashkia A, Modaresi MH.
    Protein Pept Lett; 2017 Jan 17; 24(3):190-196. PubMed ID: 28000571
    [Abstract] [Full Text] [Related]

  • 4. Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies.
    Bolhassani A, Zahedifard F, Taghikhani M, Rafati S.
    Vaccine; 2008 Jun 19; 26(26):3362-70. PubMed ID: 18471945
    [Abstract] [Full Text] [Related]

  • 5. Immunomodulatory effects of IP-10 chemokine along with PEI600-Tat delivery system in DNA vaccination against HPV infections.
    Mohit E, Bolhassani A, Zahedifard F, Seyed N, Eslamifar A, Taghikhani M, Samimi-Rad K, Rafati S.
    Mol Immunol; 2013 Jan 19; 53(1-2):149-60. PubMed ID: 22926003
    [Abstract] [Full Text] [Related]

  • 6. Enhancement of therapeutic DNA vaccine potency by melatonin through inhibiting VEGF expression and induction of antitumor immunity mediated by CD8+ T cells.
    Baghban Rahimi S, Mohebbi A, Vakilzadeh G, Biglari P, Razeghi Jahromi S, Mohebi SR, Shirian S, Gorji A, Ghaemi A.
    Arch Virol; 2018 Mar 19; 163(3):587-597. PubMed ID: 29149434
    [Abstract] [Full Text] [Related]

  • 7. Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.
    Seo SH, Jin HT, Park SH, Youn JI, Sung YC.
    Vaccine; 2009 Sep 25; 27(42):5906-12. PubMed ID: 19651174
    [Abstract] [Full Text] [Related]

  • 8. Strong immune responses induced by a DNA vaccine containing HPV16 truncated E7 C-terminal linked to HSP70 gene.
    Meshkat Z, Soleimanjahi H, Mirshahabi H, Meshkat M, Kheirandish M, Hassan ZM.
    Iran J Immunol; 2011 Jun 25; 8(2):65-75. PubMed ID: 21705833
    [Abstract] [Full Text] [Related]

  • 9. A novel therapeutic fusion protein vaccine by two different families of heat shock proteins linked with HPV16 E7 generates potent antitumor immunity and antiangiogenesis.
    Liu B, Ye D, Song X, Zhao X, Yi L, Song J, Zhang Z, Zhao Q.
    Vaccine; 2008 Mar 04; 26(10):1387-96. PubMed ID: 18272260
    [Abstract] [Full Text] [Related]

  • 10. Chemo-immunotherapy using saffron and its ingredients followed by E7-NT (gp96) DNA vaccine generates different anti-tumor effects against tumors expressing the E7 protein of human papillomavirus.
    Khavari A, Bolhassani A, Alizadeh F, Bathaie SZ, Balaram P, Agi E, Vahabpour R.
    Arch Virol; 2015 Feb 04; 160(2):499-508. PubMed ID: 25395243
    [Abstract] [Full Text] [Related]

  • 11. A novel self-assembled nanoparticle vaccine with HIV-1 Tat₄₉₋₅₇/HPV16 E7₄₉₋₅₇ fusion peptide and GM-CSF DNA elicits potent and prolonged CD8⁺ T cell-dependent anti-tumor immunity in mice.
    Tang J, Yin R, Tian Y, Huang Z, Shi J, Fu X, Wang L, Wu Y, Hao F, Ni B.
    Vaccine; 2012 Feb 01; 30(6):1071-82. PubMed ID: 22178528
    [Abstract] [Full Text] [Related]

  • 12. DNA vaccine encoding HPV-16 E7 with mutation in L-Y-C-Y-E pRb-binding motif induces potent anti-tumor responses in mice.
    Bahrami AA, Ghaemi A, Tabarraei A, Sajadian A, Gorji A, Soleimanjahi H.
    J Virol Methods; 2014 Sep 01; 206():12-8. PubMed ID: 24880067
    [Abstract] [Full Text] [Related]

  • 13. Antitumor therapeutic and antimetastatic activity of electroporation-delivered human papillomavirus 16 E7 DNA vaccines: a possible mechanism for enhanced tumor control.
    Lee IH, Park JB, Cheong M, Choi YS, Park D, Sin JI.
    DNA Cell Biol; 2011 Dec 01; 30(12):975-85. PubMed ID: 21649506
    [Abstract] [Full Text] [Related]

  • 14. Noncarrier naked antigen-specific DNA vaccine generates potent antigen-specific immunologic responses and antitumor effects.
    Chen CA, Chang MC, Sun WZ, Chen YL, Chiang YC, Hsieh CY, Chen SM, Hsiao PN, Cheng WF.
    Gene Ther; 2009 Jun 01; 16(6):776-87. PubMed ID: 19357714
    [Abstract] [Full Text] [Related]

  • 15. Gene gun administration of therapeutic HPV DNA vaccination restores the efficacy of prolonged defrosted viral based vaccine.
    Lin CT, Yen CF, Shaw SW, Yen TC, Chen YJ, Soong YK, Lai CH.
    Vaccine; 2009 Dec 09; 27(52):7352-8. PubMed ID: 19781679
    [Abstract] [Full Text] [Related]

  • 16. A non-pathogenic live vector as an efficient delivery system in vaccine design for the prevention of HPV16 E7-overexpressing cancers.
    Hosseinzadeh S, Bolhassani A, Rafati S, Taheri T, Zahedifard F, Daemi A, Taslimi Y, Hashemi M, Memarnejadian A.
    Drug Deliv; 2013 Dec 09; 20(3-4):190-8. PubMed ID: 23745741
    [Abstract] [Full Text] [Related]

  • 17. Recombinant Leishmania tarentolae encoding the HPV type 16 E7 gene in tumor mice model.
    Salehi M, Taheri T, Mohit E, Zahedifard F, Seyed N, Taslimi Y, Sattari M, Bolhassani A, Rafati S.
    Immunotherapy; 2012 Nov 09; 4(11):1107-20. PubMed ID: 23194361
    [Abstract] [Full Text] [Related]

  • 18. A novel fusion protein-based vaccine comprising a cell penetrating and immunostimulatory peptide linked to human papillomavirus (HPV) type 16 E7 antigen generates potent immunologic and anti-tumor responses in mice.
    Granadillo M, Vallespi MG, Batte A, Mendoza O, Soria Y, Lugo VM, Torrens I.
    Vaccine; 2011 Jan 29; 29(5):920-30. PubMed ID: 21145912
    [Abstract] [Full Text] [Related]

  • 19. Prophylactic and therapeutic efficacy of an attenuated Listeria monocytogenes-based vaccine delivering HPV16 E7 in a mouse model.
    Jia Y, Yin Y, Duan F, Fu H, Hu M, Gao Y, Pan Z, Jiao X.
    Int J Mol Med; 2012 Dec 29; 30(6):1335-42. PubMed ID: 23027427
    [Abstract] [Full Text] [Related]

  • 20. HSP70 modified response against HPV based tumor.
    Farzanehpour M, Soleimanjahi H, Hassan ZM, Amanzadeh A, Ghaemi A, Fazeli M.
    Eur Rev Med Pharmacol Sci; 2013 Jan 29; 17(2):228-34. PubMed ID: 23377813
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.